When did RxSight, Inc. report Q4 2024 earnings?

RxSight, Inc. (RXST) reported Q4 2024 earnings on February 25, 2025 after market close.

What were RxSight, Inc.'s Q4 2024 revenue and EPS?

RxSight, Inc. reported revenue of $40.2M and eps of $0.03 for Q4 2024.

Did RxSight, Inc. beat estimates in Q4 2024?

Revenue beat the consensus estimate of $39.8M by $433.2K. EPS missed the consensus estimate of $0.10 by $0.07.

Where can I find RxSight, Inc.'s Q4 2024 SEC filings?

You can read the 10-K periodic report (0000950170-25-026681) directly on SEC EDGAR. The filing index links above go to sec.gov.

RxSight, Inc. RXST Q4 2024 Annual earnings

Reported February 25, 2025 · After market close

Revenue$40.2MBeat by $433.2K

EPS$0.03Miss by $0.07

Revenue estimate$39.8M

EPS estimate$0.10

Next report

Aug 5, 2026 (In 1 week)

Revenue estimate$32.5M

EPS estimate-$0.21

Financials

Q4 2024

Income statement

See full

Revenue$40.2M+40.7%

Gross profit$28.8M+63.1%

Operating income-$8.6M+20.5%

Net income-$5.9M+35.3%

EPS (diluted)-$0.15+40.0%

Balance sheet

See full

Cash & equivalents$16.7M+72.4%

Total debt$12.3M+308%

Total equity$281.2M+75.4%

Total assets$318.6M+74.5%

Cash flow

See full

Operating cash flow-$4.3M+48.7%

CapEx$847.0K-46.8%

Free cash flow-$5.1M+48.4%

Valuation & ratios

Valuation

as of 12/31/24

See full

Market cap$1.39B-4.4%

Enterprise value$1.38B-4.3%

P/S9.9×-6.4×

Profitability

See full

Gross margin70.7%+10.4pp

Operating margin-26.3%-9.1pp

Net margin-19.6%-7.7pp

FCF margin-16%-6.5pp

Returns & leverage

See full

Return on equity-12.4%-5.0pp

Debt / equity0×0.0×

Current ratio11.4×+3.3×

Segments

By product

See full

Rxlal$28.5M+60.4%

LDD$10.7M+7.1%

Service Warranty Service Contracts And Accessories$1.0M+22.4%

Versus estimates

Revenue

Q1 2026$30.9MBeat by $1.1M Q4 2025$32.6MBeat by $2.4M Q3 2025$30.3MMiss by $2.3M Q2 2025$33.6MBeat by $7.9M Q1 2025$37.9MIn line

Q4 2024$40.2MBeat by $433.2K

Diluted EPS

Q1 2026-$0.38Miss by $0.08 Q4 2025-$0.22Beat by $0.11 Q3 2025-$0.04Beat by $0.15 Q2 2025-$0.08Beat by $0.02 Q1 2025-$0.03Beat by $0.01

Q4 2024$0.03Miss by $0.07

Ask the moment RxSight, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did RxSight, Inc. report Q4 2024 earnings?: RxSight, Inc. (RXST) reported Q4 2024 earnings on February 25, 2025 after market close.
What were RxSight, Inc.'s Q4 2024 revenue and EPS?: RxSight, Inc. reported revenue of $40.2M and eps of $0.03 for Q4 2024.
Did RxSight, Inc. beat estimates in Q4 2024?: Revenue beat the consensus estimate of $39.8M by $433.2K. EPS missed the consensus estimate of $0.10 by $0.07.
Where can I find RxSight, Inc.'s Q4 2024 SEC filings?: You can read the 10-K periodic report (0000950170-25-026681) directly on SEC EDGAR. The filing index links above go to sec.gov.